AI assistant
Dr. Lal Pathlabs Limited — Capital/Financing Update 2019
Nov 8, 2019
61783_rns_2019-11-08_fa66c575-db59-457d-a230-0c8b48b0493c.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [24 x 46] intentionally omitted <==
==> picture [253 x 30] intentionally omitted <==
November 8, 2019
The National Stock Exchange of India Limited Exchange Plaza Sandra Kurla Complex, Sandra (E) Mumbai - 400051
The Bombay Stock Exchange Limited 15[th ] Floor, Phiroze Jeejeeboy Towers Dalal Street, Mumbai -400001
Subject: Unaudited Financial Results for the Quarter & Half Year ended September 30, 2019 and declaration of Interim Dividend.
Ref: Regulation 30 & 33 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015 (hereinafter referred as Listing Regulations)
Dear Sir/Madam,
Please take note that the Board of Directors in their meeting held today i.e. November 8, 2019 approved Unaudited Standalone & Consolidated Financial Results of the Company for the Quarter & Half Year ended September 30, 2019.
A copy of the Results along with Limited Review Report issued by the Statutory Auditors Mis Deloitte Haskins & Sells, LLP on such financials for the Quarter & Half Year ended September 30, 2019 is attached herewith.
At the said Meeting, the Board of Directors have also declared an interim dividend of Rs. 6 /- per equity share (@ 60% on a face value of Rs. 10/- per share) for the Financial Year 2019-20.
Also, kindly take note that the Board has fixed November 21, 2019 as the record date for the purpose of payment of interim dividend. The interim dividend will be paid by the Company on or afterNovember30,2019.
The Board Meeting commenced at 12:30 PM and concluded at 2:25 PM.
We request you to please take the same on record.
Thanking You,
Yours Faithfully,
bs Limited
==> picture [51 x 35] intentionally omitted <==
a � Company Secretary and Legal Head Encl: As above
==> picture [128 x 5] intentionally omitted <==
Regd. Office: Dr. Lal PathLabs Ltd., Block E, Seaor-18, Rohini, New Delhi - 110085, 'D +9I-l I-30258600, Fax: +91-l l-2788-2134 Corporate Office: Dr. Lal PathLabs Ltd., 12th Floor, Tower 8, SAS Tower. Medicity, Sector-38, Gurugram - 122 001, Haryana c; +91-124-3016-500, Fax: +91-124-4234-468